Updates in Therapies of Relapsed and Refractory Follicular Lymphoma

home / oncview / updates-in-therapies-of-relapsed-and-refractory-follicular-lymphoma

Javier L. Munoz, MD, MS, FACP, explains the treatment options for relapsed/refractory follicular lymphoma and provides insight into a recent clinical trial.

Current Treatment Options for Relapsed/Refractory Follicular Lymphoma

EP. 1: Current Treatment Options for Relapsed/Refractory Follicular Lymphoma

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl
July 6th 2021

Javier L. Munoz, MD, MS, FACP, describes the effects of R/R FL and discusses the current treatment options available.

Factors in Choosing Relapsed/Refractory Follicular Lymphoma Treatments

EP. 2: Factors in Choosing Relapsed/Refractory Follicular Lymphoma Treatments

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl
July 6th 2021

A specialist explains the factors considered when it comes to choosing treatments for patients with relapsed/refractory follicular lymphoma, and the clinical endpoints to look for.

Treatment Options for Third Line R/R FL

EP. 3: Treatment Options for Third Line R/R FL

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl
July 13th 2021

Javier L. Munoz, MD, MS, FACP, describes the current third-line treatment options available for relapsed/refractory follicular lymphoma.

Use of Tazemetostat for R/R FL

EP. 4: Use of Tazemetostat for R/R FL

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl
July 13th 2021

An expert in relapsed/refractory follicular lymphoma discusses the approval of tazemetostat as a treatment and reviews the phase 2 clinical trial data.

Changes in Sequencing of R/R FL Therapies

EP. 5: Changes in Sequencing of R/R FL Therapies

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl
July 20th 2021

Javier L. Munoz, MD, MS, FACP, discusses how the sequencing of therapies has changed in the last year.